Cite
HARVARD Citation
Wong, E. et al. (2020). Nivolumab induces dynamic alterations in CD8 T-cell function and TIM-3 expression when used to treat relapsed acute myeloid leukemia after allogeneic stem cell transplantation. Leukemia & lymphoma. 61 (1), pp. 185-188. [Online].